Title: Open Source Clinical Trials
Focus: Area of focus
Rationale: Rationale
Expected Output: Expected output
Leader's Ideal Profile: Some experience conducting clinical trials.
Group Leader: Initial sub-group leader
Notes: Many un-tested yet promising non-chemical treatments. Pharma companies have absolutely no interest. Open Source Clinical Trials: contribute your time; your body; your IT resources. Leverage well-established framework; training; reporting mechanisms. Open Medicine; PLoS; BioMed Central http://www.ctnbestpractices.org; http://www.clinicalresearchnetworks.org Extend ePCRN globally (URL to Kevin Peterson’s ePCRN). Duke: a Sourceforge.net for open clinical trials? Public Health-oriented; community-based clinical trials. Currently; consumers are willing to donate their PC cycles to listen for signs of extraterrestrial activity (SETI@home ); and to crack biomedical challenges (Genome@Home ). Therefore; would consumers be willing to join clinical trials-like projects and to contribute de-personalized data to analyze environmental and Public Health issues?
Group's Title
Open Source Clinical Trials
Focus
Area of focus
Rationale
Rationale
Expected Output
Expected output
Ideal Leader Profile
Some experience conducting clinical trials.
Group's Leader
Initial sub-group leader
Notes
Many un-tested yet promising non-chemical treatments. Pharma companies have absolutely no interest. Open Source Clinical Trials: contribute your time; your body; your IT resources. Leverage well-established framework; training; reporting mechanisms. Open Medicine; PLoS; BioMed Central http://www.ctnbestpractices.org; http://www.clinicalresearchnetworks.org Extend ePCRN globally (URL to Kevin Peterson’s ePCRN). Duke: a Sourceforge.net for open clinical trials? Public Health-oriented; community-based clinical trials. Currently; consumers are willing to donate their PC cycles to listen for signs of extraterrestrial activity (SETI@home ); and to crack biomedical challenges (Genome@Home ). Therefore; would consumers be willing to join clinical trials-like projects and to contribute de-personalized data to analyze environmental and Public Health issues?
